Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dolomite and GigaGen Collaborate to Develop Novel Droplet Merging Technology

Published: Friday, February 17, 2012
Last Updated: Friday, February 17, 2012
Bookmark and Share
Development of a novel Droplet Merger Chip for massively parallel single cell genetic analysis.

Dolomite has announced its collaboration with GigaGen Inc. (San Francisco, CA) in the development of a novel Droplet Merger Chip for massively parallel single cell genetic analysis.

Measuring just 15mm x 22.5mm, the novel glass microfluidic chip facilitates fast and consistent merging of two individual droplet streams, benefiting a wide range of applications including DNA amplification, biochemical analysis, single cell analysis and high throughput experimentation.

Unlike other methods which incorporate expensive and bulky high voltage electronics to merge droplets using electrostatic forces, the Droplet Merger Chip works by simply “squeezing” droplets together in a carefully designed merging chamber.

The result is a unique microfluidic device, which points the way to low cost disposable chips in future versions.

“A simple and reliable droplet merging technology is an important step forward for us”, said Dr. David Johnson, CEO and founder of GigaGen Inc., adding “We are now using these chips in our game-changing system for massively parallel single cell genetic analysis.”

GigaGen Inc. filed a patent application describing the chip design and its applications in the field of genetic analysis of cells.

As part of a license agreement with GigaGen Inc., Dolomite will be offering the technology later this year to research users in academia and commercial users in a wide range of application areas.

“Many of our customers have asked us for chips to create droplets, merge them, and then carry out further processing and analysis”, commented Dr. Andrew Lovatt, CEO of Dolomite.

Dr. Lovatt continued, “Our partnership with Sphere Fluidics gives us additional capability in selecting the surfactants we use, to optimize droplet behaviour and stability under a wide range of temperature and biological conditions.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Enter the Dolomite and Lab on a Chip Productizing Science® Competition 2015 Now!
Don’t miss the chance to drive microfluidics innovation forwards.
Thursday, April 23, 2015
Dolomite and Lab on a Chip Launch Productizing Science® Competition 2015
Competition offers the opportunity to take advantage of Dolomite’s invaluable commercial expertise and in-depth understanding of the international microfluidics market.
Wednesday, October 08, 2014
Dolomite Announces Exclusive Agreement with Fluika
Agreement for the sale of compact microfluidic pressure and vacuum pumps for pneumatic control systems in microfluidics, chemistry and mechatronics.
Tuesday, August 05, 2014
Dolomite Announces 2013 Productizing Science® Competition Winner
Fully automated DNA lab-on-a-chip microfluidic system wins Dolomite’s competition.
Tuesday, June 10, 2014
Dolomite Microfluidics, Sphere Fluidics Partner
Agreement will see companies deliver world leading droplet based technology.
Thursday, May 01, 2014
R&D Consortium to Develop Optical Sorting of Stem Cells
Dolomite is collaborating with European technology leaders over a two year publicly funded consortium.
Tuesday, December 17, 2013
Epigem and Dolomite Join Forces
Both Companies announces collaboration in the design and manufacture of microfluidic devices.
Wednesday, March 13, 2013
Dolomite Celebrates a Successful 2012
Microfluidics company Dolomite has reported an exceptional 20% year-on-year growth in 2012.
Tuesday, February 12, 2013
Dolomite Announces Microdroplet IP License Arrangements with JST
Dolomite offers a wide range of Droplet-forming devices.
Friday, August 24, 2012
Dolomite’s Launches Productizing Science™ Competition
New competition offering the chance to productize scientific discoveries.
Monday, June 18, 2012
Dolomite Joins Forces with LioniX B.V.
Companies join forces in the areas of designing, developing and fabricating microfluidic devices and systems.
Thursday, May 03, 2012
Microfluidics Specialist Dolomite Signs Collaboration Agreement with Sphere Fluidics
Sphere Fluidics offers extensive expertise in miniaturized Discovery Systems and Services based on microfluidics and picodroplets.
Wednesday, May 11, 2011
Dolomite and Emerald BioSystems collaborate to produce award winning novel protein crystallography instrument
Dolomite is delighted to announce its collaboration with Emerald BioSystems in the development of the Microcapillary Protein Crystallization System (MPCS) Plug Maker™.
Tuesday, March 16, 2010
Microfluidic Application Centre Appoints Gillian Davis to Strategic Commercial Role
Dr. Gillian will be instrumental in securing new business opportunities and managing customer relations at Dolomite microfluidic capabilities and services.
Monday, September 17, 2007
Pushing the Boundaries of Microfluidics
New Expert Advisory Group is formed to advance Dolomite’s growing application areas.
Thursday, November 09, 2006
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!